AI assistant
Health Catalyst, Inc. — Director's Dealing 2021
Mar 4, 2021
33681_dirs_2021-03-03_f5a25f4b-dd32-4130-b752-63ac19f6e3a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-03-01
Reporting Person: Nelli James Patrick Jr. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock | M | 4335.00 | $10.72 | Acquired | 150183.00 | Direct |
| 2021-03-01 | Common Stock | M | 15665.00 | $10.80 | Acquired | 165848.00 | Direct |
| 2021-03-01 | Common Stock | S | 900.00 | $49.6126 | Disposed | 164948.00 | Direct |
| 2021-03-01 | Common Stock | S | 25350.00 | $48.6102 | Disposed | 139598.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Stock Option (Right to Buy) | $10.80 | M | 15665.00 | Disposed | 2028-09-27 | Common Stock (15665.00) | Direct |
| 2021-03-01 | Stock Option (Right to Buy) | $10.72 | M | 4335.00 | Disposed | 2027-10-26 | Common Stock (4335.00) | Direct |
Footnotes
F1: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1.
F2: Represents the weighted average sale price of the shares sold ranging from $49.29 to $49.92 per share, inclusive.
F3: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.19 to $49.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
F4: 25% of the 215,741 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.
F5: 25% of the 80,977 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on October 26, 2021.